Once a sci­en­tif­ic back­wa­ter, pro­tein re­search at­tracts bil­lion-dol­lar deals and high-pro­file pub­li­ca­tions

When it comes to de­tect­ing dis­ease and un­der­stand­ing how the body works, pro­tein re­search has long been over­shad­owed by DNA se­quenc­ing.

But the field, known as pro­teomics, has seen a surge of ac­tiv­i­ty in re­cent months. Larg­er play­ers have struck bil­lion-dol­lar-plus deals, a pro­posed $1.4 bil­lion in­ter­na­tion­al col­lab­o­ra­tion has launched, and new re­search has shown that a pro­teomics can­cer di­ag­nos­tic might chal­lenge some of the DNA-based play­ers that cur­rent­ly dom­i­nate that field.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER